secwatch.observer — SEC 8-K summary
======================================

Issuer:     PULSE BIOSCIENCES, INC. (PLSE)
CIK:        0001625101
Form:       8-K
Filed at:   2021-10-06T23:59:59+00:00
Accession:  0001625101-21-000050
Event type: leadership
Sentiment:  neutral
Materiality: 0.35
Item codes: 5.02, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Pulse Biosciences appoints Laureen DeBuono to board, Kenneth Clark resigns
--------------------------------------------------------------------------

- Kenneth Clark resigned from Board on Oct 4; holds vested options for 150,574 shares at $10.66-$23.08.
- Laureen DeBuono elected to Board; will serve on Audit Committee and chair Nominating Committee.
- DeBuono received initial grant of 32,500 stock options; annual retainers: $40k board, $10k Audit, $10k Nominating Chair.
- Chief Strategy Officer Mr. Levinson designated as an executive officer under the Exchange Act.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1625101/000162510121000050/0001625101-21-000050-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1625101/000162510121000050/plse-20211004x8k.htm
  HTML page:      https://secwatch.observer/filing/0001625101-21-000050

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer